Simon A. Williams

1.2k total citations
26 papers, 995 citations indexed

About

Simon A. Williams is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Simon A. Williams has authored 26 papers receiving a total of 995 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Simon A. Williams's work include Prostate Cancer Treatment and Research (6 papers), AI in cancer detection (5 papers) and Radiomics and Machine Learning in Medical Imaging (4 papers). Simon A. Williams is often cited by papers focused on Prostate Cancer Treatment and Research (6 papers), AI in cancer detection (5 papers) and Radiomics and Machine Learning in Medical Imaging (4 papers). Simon A. Williams collaborates with scholars based in United States, Australia and United Kingdom. Simon A. Williams's co-authors include David J. McConkey, Samuel R. Denmeade, John T. Isaacs, Keyi Zhu, Curtis A. Pettaway, Christos N. Papandreou, Christopher J. Logothetis, Pratap Singh, Colin P. Dinney and Laura M. Lashinger and has published in prestigious journals such as The Journal of Immunology, Cancer Research and Pattern Recognition.

In The Last Decade

Simon A. Williams

26 papers receiving 971 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simon A. Williams United States 15 526 344 192 185 101 26 995
Tim P. Green United Kingdom 13 699 1.3× 504 1.5× 133 0.7× 159 0.9× 68 0.7× 14 1.2k
J. Rafael Sierra United States 11 582 1.1× 364 1.1× 133 0.7× 249 1.3× 59 0.6× 18 1.1k
Xiao-Feng Le United States 21 910 1.7× 462 1.3× 274 1.4× 92 0.5× 155 1.5× 23 1.3k
Honor J. Hugo Australia 15 520 1.0× 433 1.3× 238 1.2× 126 0.7× 59 0.6× 29 927
P. Charles Lin United States 10 417 0.8× 232 0.7× 194 1.0× 95 0.5× 52 0.5× 11 799
Toshiyuki Isoe Japan 16 623 1.2× 385 1.1× 110 0.6× 145 0.8× 32 0.3× 30 935
JEFF EVANS United Kingdom 6 617 1.2× 397 1.2× 278 1.4× 98 0.5× 62 0.6× 24 1.2k
Julie Litz United States 18 885 1.7× 511 1.5× 155 0.8× 144 0.8× 41 0.4× 20 1.4k
Zhenfang Du China 15 776 1.5× 404 1.2× 227 1.2× 279 1.5× 74 0.7× 34 1.3k
John S. Yordy United States 18 788 1.5× 605 1.8× 353 1.8× 346 1.9× 135 1.3× 32 1.5k

Countries citing papers authored by Simon A. Williams

Since Specialization
Citations

This map shows the geographic impact of Simon A. Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon A. Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon A. Williams more than expected).

Fields of papers citing papers by Simon A. Williams

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon A. Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon A. Williams. The network helps show where Simon A. Williams may publish in the future.

Co-authorship network of co-authors of Simon A. Williams

This figure shows the co-authorship network connecting the top 25 collaborators of Simon A. Williams. A scholar is included among the top collaborators of Simon A. Williams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon A. Williams. Simon A. Williams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Manning, Michael L., Simon A. Williams, Christine Jelinek, Maya Kostova, & Samuel R. Denmeade. (2013). Proteolysis of Complement Factors iC3b and C5 by the Serine Protease Prostate-Specific Antigen in Prostatic Fluid and Seminal Plasma. The Journal of Immunology. 190(6). 2567–2574. 21 indexed citations
2.
Williams, Simon A., et al.. (2013). Background intensity independent texture features for assessing breast cancer risk in screening mammograms. Pattern Recognition Letters. 34(9). 1053–1062. 12 indexed citations
3.
Williams, Simon A., et al.. (2013). Constructing and applying higher order textons: Estimating breast cancer risk. Pattern Recognition. 47(3). 1375–1382. 7 indexed citations
4.
5.
Manning, Michael L., Maya Kostova, Simon A. Williams, & Samuel R. Denmeade. (2011). Trypsin‐like proteolytic contamination of commercially available psa purified from human seminal fluid. The Prostate. 72(11). 1233–1238. 5 indexed citations
6.
Williams, Simon A., Christine Jelinek, Ivan V. Litvinov, et al.. (2011). Enzymatically active prostate‐specific antigen promotes growth of human prostate cancers. The Prostate. 71(15). 1595–1607. 41 indexed citations
7.
Williams, Simon A., Yi Xu, Angelo M. De Marzo, John T. Isaacs, & Samuel R. Denmeade. (2010). Prostate‐specific antigen (PSA) is activated by KLK2 in prostate cancer ex vivo models and in prostate‐targeted PSA/KLK2 double transgenic mice. The Prostate. 70(7). 788–796. 29 indexed citations
8.
Bajger, Mariusz, Fei Ma, Simon A. Williams, & Murk J. Bottema. (2010). Mammographic Mass Detection with Statistical Region Merging. 2879. 27–32. 13 indexed citations
9.
Strickland, Laura A, Jed Ross, Simon A. Williams, et al.. (2009). Preclinical evaluation of carcinoembryonic cell adhesion molecule (CEACAM) 6 as potential therapy target for pancreatic adenocarcinoma. The Journal of Pathology. 218(3). 380–390. 51 indexed citations
10.
Williams, Simon A., et al.. (2008). Extended‐release PEG–luciferin allows for long‐term imaging of firefly luciferase activity in vivo. Luminescence. 24(1). 35–38. 11 indexed citations
11.
Kumar, Srinivas K., Simon A. Williams, John T. Isaacs, Samuel R. Denmeade, & Saeed R. Khan. (2007). Modulating paclitaxel bioavailability for targeting prostate cancer. Bioorganic & Medicinal Chemistry. 15(14). 4973–4984. 45 indexed citations
12.
Browning, Jeffrey L., Ralph J. Abi‐Habib, Simon A. Williams, et al.. (2007). Recombinant prostate-specific antigen proaerolysin shows selective protease sensitivity and cell cytotoxicity. Anti-Cancer Drugs. 18(7). 809–816. 12 indexed citations
13.
Singh, Pratap, Simon A. Williams, Meha H. Shah, et al.. (2007). Mechanistic insights into the inhibition of prostate specific antigen by β‐lactam class compounds. Proteins Structure Function and Bioinformatics. 70(4). 1416–1428. 19 indexed citations
14.
Williams, Simon A., Pratap Singh, John T. Isaacs, & Samuel R. Denmeade. (2006). Does PSA play a role as a promoting agent during the initiation and/or progression of prostate cancer?. The Prostate. 67(3). 312–329. 78 indexed citations
15.
Aggarwal, Saurabh, Rebecca M. Ricklis, Simon A. Williams, & Samuel R. Denmeade. (2006). Comparative study of PSMA expression in the prostate of mouse, dog, monkey, and human. The Prostate. 66(9). 903–910. 34 indexed citations
16.
Lashinger, Laura M., Keyi Zhu, Simon A. Williams, et al.. (2005). Bortezomib Abolishes Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Resistance via a p21-Dependent Mechanism in Human Bladder and Prostate Cancer Cells. Cancer Research. 65(11). 4902–4908. 94 indexed citations
17.
Liu, Wenbiao, Niels Reinmuth, Oliver Stoeltzing, et al.. (2003). Cyclooxygenase-2 is up-regulated by interleukin-1 beta in human colorectal cancer cells via multiple signaling pathways.. PubMed. 63(13). 3632–6. 118 indexed citations
18.
Williams, Simon A. & David J. McConkey. (2003). The proteasome inhibitor bortezomib stabilizes a novel active form of p53 in human LNCaP-Pro5 prostate cancer cells.. PubMed. 63(21). 7338–44. 79 indexed citations
19.
Williams, Simon A., et al.. (2003). Differential effects of the proteasome inhibitor bortezomib on apoptosis and angiogenesis in human prostate tumor xenografts.. PubMed. 2(9). 835–43. 137 indexed citations
20.
Roberts, M M, et al.. (1984). Risk of breast cancer in women with history of benign disease of the breast.. BMJ. 288(6413). 275–278. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tim P. Green Breakdown of academic impact, for papers by J. Rafael Sierra Breakdown of academic impact, for papers by Xiao-Feng Le Breakdown of academic impact, for papers by Honor J. Hugo Breakdown of academic impact, for papers by P. Charles Lin Breakdown of academic impact, for papers by Toshiyuki Isoe Breakdown of academic impact, for papers by JEFF EVANS Breakdown of academic impact, for papers by Julie Litz Breakdown of academic impact, for papers by Zhenfang Du Breakdown of academic impact, for papers by John S. Yordy
Rankless by CCL
2026